Related Experiment Video
Updated: May 30, 2026
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Insights
Routine HIV testing in healthcare settings can reduce late diagnoses. Many individuals with HIV remain unaware of their status, leading to late-stage disease and poorer health outcomes.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Clinical Medicine
Background:
- In 2009, an estimated 86,500 individuals in the UK were living with HIV, with approximately 25% undiagnosed.
- Half of adults diagnosed with HIV in 2009 presented with late-stage disease (CD4 < 350 cells/μL or AIDS-defining event).
- Late HIV diagnosis is linked to increased morbidity, mortality, poorer treatment response, and higher healthcare costs.
Purpose of the Study:
- To examine the issues surrounding routine HIV testing in healthcare settings.
- To explore strategies for reducing late HIV diagnoses through increased testing uptake.
- To highlight the benefits of early HIV detection and intervention.
Main Methods:
- Review of existing data on HIV prevalence and diagnosis in the UK.
- Analysis of testing uptake rates in genitourinary medicine (GUM) clinics and antenatal care.
- Discussion of the potential impact of expanding routine HIV testing to other healthcare settings.
Main Results:
- Routine HIV testing in GUM clinics and antenatal settings demonstrates high uptake.
- Late diagnosis remains a significant issue, indicating missed opportunities for early intervention.
- Expanding routine testing is proposed as a strategy to improve early detection rates.
Conclusions:
- Increasing routine HIV testing across diverse healthcare settings is crucial for reducing late diagnoses.
- Early HIV diagnosis facilitates timely treatment, improves patient outcomes, and aids prevention efforts.
- Addressing undiagnosed HIV infections through systematic testing is a key public health priority.
Abstract:
In 2009, around 86,500 people in the UK had HIV infection, of whom around a quarter were unaware of their condition. Of adults diagnosed in that year, around half were already at a late stage of disease (with a CD4 count below 350 cells/μL or presenting with an AIDS-defining event). Such late diagnosis represents a missed opportunity for treatment and prevention, and is associated with significant morbidity and mortality, reduced response to antiretroviral drugs and increased healthcare costs. In genitourinary medicine (GUM) clinics and during antenatal care, there is a high uptake rate of routine testing (i.e. HIV tests are offered as part of standard care and the individual has the option to decline). Increasing such testing across other healthcare settings could reduce late diagnosis. Here we examine issues around routine HIV testing.
More Related Videos
Related Concept Videos
01:26Sexually Transmitted Infections
01:10Retrovirus Life Cycles